Keybank National Association OH Grows Position in Option Care Health, Inc. (NASDAQ:OPCH)

Keybank National Association OH boosted its stake in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 15.4% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 18,613 shares of the company’s stock after purchasing an additional 2,489 shares during the period. Keybank National Association OH’s holdings in Option Care Health were worth $432,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of OPCH. FMR LLC grew its position in Option Care Health by 134.0% during the 3rd quarter. FMR LLC now owns 7,516,448 shares of the company’s stock worth $235,265,000 after purchasing an additional 4,304,896 shares during the last quarter. Victory Capital Management Inc. grew its position in Option Care Health by 4,432.8% during the 3rd quarter. Victory Capital Management Inc. now owns 1,621,593 shares of the company’s stock worth $50,756,000 after purchasing an additional 1,585,818 shares during the last quarter. Wellington Management Group LLP grew its position in Option Care Health by 15.5% during the 3rd quarter. Wellington Management Group LLP now owns 9,924,915 shares of the company’s stock worth $310,650,000 after purchasing an additional 1,328,326 shares during the last quarter. Geneva Capital Management LLC purchased a new stake in Option Care Health during the 3rd quarter worth approximately $24,679,000. Finally, Westfield Capital Management Co. LP grew its position in Option Care Health by 10.2% during the 3rd quarter. Westfield Capital Management Co. LP now owns 6,492,152 shares of the company’s stock worth $203,204,000 after purchasing an additional 599,589 shares during the last quarter. Hedge funds and other institutional investors own 98.05% of the company’s stock.

Option Care Health Trading Down 0.7 %

Shares of OPCH stock opened at $34.01 on Monday. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32. The firm has a market cap of $5.62 billion, a PE ratio of 28.58, a price-to-earnings-growth ratio of 2.30 and a beta of 1.33. The company has a 50-day moving average of $29.83 and a two-hundred day moving average of $28.16. Option Care Health, Inc. has a 1-year low of $21.39 and a 1-year high of $34.85.

Insider Transactions at Option Care Health

In related news, insider Michael Bavaro sold 30,996 shares of the firm’s stock in a transaction that occurred on Friday, February 28th. The shares were sold at an average price of $33.26, for a total value of $1,030,926.96. Following the sale, the insider now owns 44,974 shares of the company’s stock, valued at $1,495,835.24. This trade represents a 40.80 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 0.64% of the company’s stock.

Analyst Upgrades and Downgrades

OPCH has been the topic of several recent research reports. JMP Securities reaffirmed a “market outperform” rating and issued a $30.00 price objective (down from $31.00) on shares of Option Care Health in a report on Friday, January 10th. Bank of America raised shares of Option Care Health from a “neutral” rating to a “buy” rating and upped their price objective for the company from $26.00 to $33.00 in a report on Monday, January 13th. Jefferies Financial Group raised shares of Option Care Health from a “hold” rating to a “buy” rating and upped their price objective for the company from $26.00 to $35.00 in a report on Thursday, January 23rd. JPMorgan Chase & Co. upped their price objective on shares of Option Care Health from $40.00 to $41.00 and gave the company an “overweight” rating in a report on Thursday. Finally, UBS Group initiated coverage on shares of Option Care Health in a report on Thursday, December 5th. They issued a “neutral” rating and a $26.00 price objective on the stock. Two analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to data from MarketBeat, Option Care Health has an average rating of “Moderate Buy” and a consensus price target of $33.00.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.